| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |